Browse 2,517 respiratory clinical trials enrolling across the United States and Canada. 332 people applied to respiratory studies last month. Search by city or state to find one near you.
Filter
1
Filter results
Results: 2,517
Active & Responsive
Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough
for
Chronic Cough (CC), Refractory Chronic Cough,
Location: Atlanta GA, Missoula MT
Sponsor: University of Montana
Sex: All
Age: 18 - 70+
Code: NCT06960759
Phase 2, Recruiting
Active & Responsive
Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial
for
Non-small Cell Lung Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07382726
Phase 1, Recruiting
Active & Responsive
129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: London
Sponsor: Western University, Canada
Sex: All
Age: 50 - 70+
Code: NCT07192016
Recruiting
Active & Responsive
First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
for
Non-small Cell Lung Cancer Stage IV,
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT07355205
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Locally Advanced Non-Small Cell Lung Cancer (NSCLC),
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
for
Pulmonary Arterial Hypertension
Location: New Hyde Park NY, New York NY, Philadelphia PA,
Sponsor: Insmed Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07481981
Phase 3, Recruiting
Active & Responsive
Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?
for
Long COVID Syndrome
Location: Toronto
Sponsor: York University
Sex: All
Age: 18 - 65
Code: NCT07312409
Recruiting
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: New Haven CT, White Plains NY, Albany NY, Montreal,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase 3, Recruiting
Active & Responsive
Exploring the Use of Phototherapy to Improve CPAP Compliance
for
Obstructive Sleep Apnea
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 18+
Code: NCT06960161
Phase 1, Recruiting
Active & Responsive
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing Tonsillectomy
for
Opioid-Induced Respiratory Depression,
Location: Pittsburgh PA
Sponsor: NeurOptics Inc
Sex: All
Age: 3 - 17
Code: NCT07573150
Recruiting
Active & Responsive
Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS)
for
Bronchiectasis Adult
Location: Charleston SC, Atlanta GA, Birmingham AL
Sponsor: Synchrony-Medical, Ltd
Sex: All
Age: 21+
Code: NCT07135284
Recruiting
Active & Responsive
Upper Airway's Pressure Drop Analyses After Mandibular Advancement and Maxillary Expansion
for
Apnea, Airway Obstruction, Nasal, Mandible Small,
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 8 - 14
Code: NCT04190953
Recruiting
Active & Responsive
18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients
for
Tuberculosis, Pulmonary
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 18+
Code: NCT07077213
Recruiting
Active & Responsive
PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia